Overview
- 6 public-safe observations are available for this inspection.
- 6 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
26 May 2017
21 CFR 225.42(b)
Adequate procedures established
Cited by Michael A Feingold, Kristi B Panzer
26 May 2017
21 CFR 225.42(b)(5)
Receipt for each lot of drug received
Cited by Michael A Feingold, Kristi B Panzer
26 May 2017
21 CFR 225.42(b)(6)
Daily inventory record kept
Cited by Michael A Feingold, Kristi B Panzer
Inspected site
FMFurst McNess CoGering, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 225.120 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 225.42(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 225.42(b)(5) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 225.42(b)(6) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 225.58(b)(1) | Cited across public-safe Form 483 observations | 1x |
| FDCA 417(d)(1)(A) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 6 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere